Surgery Partners (SGRY)
Surgery Partners on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-general medical & surgical hospitals, nec.
14.3M
Short interest
settlement 2026-09-30
5.3
Days to cover
-1.0 days vs prior
48.9%
Short share of volume
2026-10-09
55,678
Fails to deliver
settlement 2026-09-11
Mon 9 Nov
Next earnings
estimated date
$144K
Insider flow, 90 days
1 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in SGRY is 14,349,417 shares, up 1,394,902 shares over the last month. Over the last 48 readings it ranged from 9,364,681 shares (30 May 2025) to 17,733,914 shares (30 January 2026). At the reported average volume of 2.7M shares a day that is 5.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/sgry" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 14,349,417 | +8.0% | 2,682,773 | 5.35 |
| 2026-09-15 | 13,288,944 | +2.6% | 2,087,270 | 6.37 |
| 2026-08-31 | 12,954,515 | +2.4% | 2,766,991 | 4.68 |
| 2026-08-14 | 12,652,439 | -6.5% | 2,099,160 | 6.03 |
| 2026-07-31 | 13,536,368 | -8.6% | 1,524,170 | 8.88 |
| 2026-07-15 | 14,803,675 | -2.1% | 1,297,770 | 11.41 |
| 2026-06-30 | 15,125,552 | +6.0% | 1,451,836 | 10.42 |
| 2026-06-15 | 14,274,524 | +4.0% | 1,326,067 | 10.76 |
| 2026-05-29 | 13,719,314 | -5.3% | 1,178,290 | 11.64 |
| 2026-05-15 | 14,485,588 | -8.4% | 2,209,501 | 6.56 |
| 2026-04-30 | 15,807,501 | -0.2% | 1,006,355 | 15.71 |
| 2026-04-15 | 15,839,348 | +13.2% | 1,120,717 | 14.13 |
| 2026-03-31 | 13,997,600 | +4.3% | 1,201,874 | 11.65 |
| 2026-03-13 | 13,422,247 | -2.8% | 2,585,684 | 5.19 |
| 2026-02-27 | 13,812,095 | -15.7% | 1,331,779 | 10.37 |
| 2026-02-13 | 16,386,395 | -7.6% | 1,952,663 | 8.39 |
| 2026-01-30 | 17,733,914 | +14.2% | 1,285,781 | 13.79 |
| 2026-01-15 | 15,535,469 | -1.9% | 1,428,975 | 10.87 |
| 2025-12-31 | 15,837,679 | +9.3% | 1,448,397 | 10.93 |
| 2025-12-15 | 14,484,597 | +2.0% | 2,074,718 | 6.98 |
| 2025-11-28 | 14,196,507 | -0.1% | 1,735,203 | 8.18 |
| 2025-11-14 | 14,211,341 | +4.0% | 3,434,846 | 4.14 |
| 2025-10-31 | 13,658,832 | -3.7% | 990,652 | 13.79 |
| 2025-10-15 | 14,180,313 | +15.5% | 1,355,313 | 10.46 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of SGRY volume is 48.9%, down 21.8 points over the last five sessions. Over the last 30 readings it ranged from 22.3% (2 September 2026) to 79.0% (17 September 2026). The latest reading is 6.1 points below the 30-session average of 55.0%, on 323K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 158K | 323K | 48.9% | 0 |
| 2026-10-08 | 140K | 208K | 67.4% | 0 |
| 2026-10-07 | 354K | 629K | 56.3% | 0 |
| 2026-10-06 | 175K | 262K | 66.9% | 0 |
| 2026-10-05 | 184K | 382K | 48.1% | 14,453 |
| 2026-10-02 | 254K | 360K | 70.7% | 0 |
| 2026-10-01 | 457K | 631K | 72.4% | 0 |
| 2026-09-30 | 267K | 442K | 60.4% | 1 |
| 2026-09-29 | 178K | 336K | 53.0% | 780 |
| 2026-09-28 | 247K | 403K | 61.5% | 0 |
| 2026-09-25 | 394K | 670K | 58.7% | 0 |
| 2026-09-24 | 323K | 611K | 52.9% | 1,502 |
| 2026-09-23 | 608K | 1.8M | 33.4% | 0 |
| 2026-09-22 | 1.6M | 4.4M | 35.2% | 2,500 |
| 2026-09-21 | 446K | 578K | 77.1% | 0 |
| 2026-09-18 | 555K | 724K | 76.7% | 0 |
| 2026-09-17 | 1.6M | 2.0M | 79.0% | 0 |
| 2026-09-16 | 362K | 481K | 75.4% | 57 |
| 2026-09-15 | 466K | 849K | 54.9% | 0 |
| 2026-09-14 | 252K | 655K | 38.5% | 0 |
| 2026-09-11 | 320K | 560K | 57.2% | 0 |
| 2026-09-10 | 633K | 1.2M | 50.8% | 0 |
| 2026-09-09 | 365K | 601K | 60.7% | 0 |
| 2026-09-08 | 465K | 900K | 51.6% | 0 |
| 2026-09-04 | 126K | 281K | 44.9% | 0 |
| 2026-09-03 | 371K | 719K | 51.6% | 0 |
| 2026-09-02 | 250K | 1.1M | 22.3% | 0 |
| 2026-09-01 | 848K | 1.6M | 53.3% | 12,078 |
| 2026-08-31 | 623K | 1.8M | 34.7% | 0 |
| 2026-08-28 | 237K | 669K | 35.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in SGRY is 55,678 shares, up 55,662 shares over the last settlement date. Over the last 30 readings it ranged from 16 shares (8 September 2026) to 203,092 shares (2 July 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 55,678 | $14.12 | $786K |
| 2026-09-08 | 16 | $14.26 | $228 |
| 2026-08-26 | 883 | $14.05 | $12K |
| 2026-08-24 | 1,877 | $14.52 | $27K |
| 2026-08-12 | 3,958 | $15.00 | $59K |
| 2026-08-11 | 2,622 | $15.95 | $42K |
| 2026-08-03 | 1,745 | $15.40 | $27K |
| 2026-07-31 | 126 | $15.90 | $2K |
| 2026-07-29 | 3,172 | $15.58 | $49K |
| 2026-07-28 | 487 | $15.17 | $7K |
| 2026-07-27 | 3,794 | $15.73 | $60K |
| 2026-07-24 | 1,430 | $15.22 | $22K |
| 2026-07-21 | 106,602 | $16.03 | $1.7M |
| 2026-07-17 | 2,692 | $16.64 | $45K |
| 2026-07-16 | 58 | $15.89 | $922 |
| 2026-07-08 | 3,031 | $17.17 | $52K |
| 2026-07-07 | 17,793 | $17.00 | $302K |
| 2026-07-06 | 2,052 | $17.23 | $35K |
| 2026-07-02 | 203,092 | $16.60 | $3.4M |
| 2026-07-01 | 132 | $16.80 | $2K |
| 2026-06-30 | 1,306 | $16.56 | $22K |
| 2026-06-25 | 4,639 | $15.22 | $71K |
| 2026-06-15 | 5,224 | $15.31 | $80K |
| 2026-06-12 | 267 | $14.94 | $4K |
| 2026-06-11 | 2,641 | $14.20 | $38K |
| 2026-06-08 | 11,933 | $13.71 | $164K |
| 2026-06-05 | 975 | $13.68 | $13K |
| 2026-06-04 | 14,456 | $13.51 | $195K |
| 2026-06-03 | 1,614 | $13.77 | $22K |
| 2026-05-20 | 4,514 | $13.69 | $62K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at SGRY reported 1 open-market buy worth $144K in the last 90 days and no open-market sells. Latest filing: DeLuca Teresa (Director) on 2026-08-18.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | DeLuca Teresa | Director | Buy | 10K | $14.35 | $144K | 67K |
| 2026-06-18 | HENDRIX BLAIR E | Director | Grant | 34K | $14.55 | $500K | 53K |
| 2026-06-05 | TURNER BRENT | Director | Grant | 12K | $13.71 | $160K | 87K |
| 2026-06-05 | HENDRIX BLAIR E | Director, 10% owner | Grant | 12K | $13.71 | $160K | 19K |
| 2026-06-05 | Forese Laura L | Director | Grant | 12K | $13.71 | $160K | 19K |
| 2026-06-05 | Deane John A | Director | Grant | 12K | $13.71 | $160K | 46K |
| 2026-06-05 | Dean Lloyd H | Director | Grant | 12K | $13.71 | $160K | 12K |
| 2026-06-05 | DeLuca Teresa | Director | Grant | 12K | $13.71 | $160K | 57K |
| 2026-06-05 | ADLERZ CLIFFORD G | Director | Grant | 12K | $13.71 | $160K | 69K |
| 2026-03-16 | Evans Jason Eric | Chief Executive Officer | Sell | 20K | $12.47 | $254K | 920K |
| 2026-03-16 | Doherty David T | Chief Financial Officer | Sell | 9K | $12.50 | $111K | 222K |
| 2026-03-13 | Burkhalter Danielle | Chief Human Resources Officer | Sell | 3K | $12.83 | $45K | 77K |
| 2026-03-13 | Brittenham Marissa | Chief Strategy Officer | Sell | 4K | $12.54 | $46K | 94K |
| 2026-03-12 | Baldock Jennifer | Chief Admin & Dev Officer | Sell | 6K | $13.17 | $76K | 326K |
| 2026-03-06 | Webb William Trenton | American Group President | Sell | 272 | $13.93 | $4K | 74K |
| 2026-03-06 | Evans Jason Eric | Chief Executive Officer | Sell | 11K | $13.79 | $158K | 663K |
| 2026-03-06 | Doherty David T | Chief Financial Officer | Sell | 15K | $13.84 | $202K | 89K |
| 2026-03-06 | Burkhalter Danielle | Chief Human Resources Officer | Sell | 8K | $13.60 | $105K | 37K |
| 2026-03-06 | Brittenham Marissa | Chief Strategy Officer | Sell | 9K | $13.70 | $120K | 55K |
| 2026-03-06 | Baldock Jennifer | Chief Admin & Dev Officer | Sell | 10K | $13.70 | $138K | 332K |
| 2026-03-05 | Webb William Trenton | American Group President | Grant | 11K | $14.11 | $161K | 104K |
| 2026-03-05 | Webb William Trenton | American Group President | Grant | 20K | $14.11 | $289K | 93K |
| 2026-03-05 | Webb William Trenton | American Group President | Sell | 2K | $13.86 | $25K | 72K |
| 2026-03-05 | Oppenheimer Justin Robert | COO & National Group President | Grant | 43K | $14.11 | $600K | 120K |
| 2026-03-05 | Evans Jason Eric | Chief Executive Officer | Grant | 136K | $14.11 | $1.9M | 941K |
| 2026-03-05 | Evans Jason Eric | Chief Executive Officer | Grant | 142K | $14.11 | $2.0M | 804K |
| 2026-03-05 | Doherty David T | Chief Financial Officer | Grant | 31K | $14.11 | $430K | 231K |
| 2026-03-05 | Doherty David T | Chief Financial Officer | Grant | 55K | $14.11 | $770K | 200K |
| 2026-03-05 | Doherty David T | Chief Financial Officer | Grant | 57K | $14.11 | $800K | 146K |
| 2026-03-05 | Burkhalter Danielle | Chief Human Resources Officer | Grant | 9K | $14.11 | $129K | 80K |
| 2026-03-05 | Burkhalter Danielle | Chief Human Resources Officer | Grant | 16K | $14.11 | $231K | 71K |
| 2026-03-05 | Burkhalter Danielle | Chief Human Resources Officer | Grant | 18K | $14.11 | $250K | 55K |
| 2026-03-05 | Brittenham Marissa | Chief Strategy Officer | Grant | 9K | $14.11 | $129K | 98K |
| 2026-03-05 | Brittenham Marissa | Chief Strategy Officer | Grant | 16K | $14.11 | $231K | 89K |
| 2026-03-05 | Brittenham Marissa | Chief Strategy Officer | Grant | 18K | $14.11 | $250K | 72K |
| 2026-03-05 | Baldock Jennifer | Chief Admin & Dev Officer | Grant | 23K | $14.11 | $323K | 342K |
| 2026-03-05 | Baldock Jennifer | Chief Admin & Dev Officer | Grant | 41K | $14.11 | $577K | 319K |
| 2026-03-05 | Baldock Jennifer | Chief Admin & Dev Officer | Grant | 43K | $14.11 | $600K | 279K |
| 2026-01-13 | Oppenheimer Justin Robert | COO & National Group President | Grant | 78K | $16.08 | $1.2M | 78K |
| 2025-09-04 | Bane Harrison R. | National Group President | Sell | 4K | $22.48 | $81K | 117K |
| 2025-09-04 | Bane Harrison R. | National Group President | Sell | 6K | $22.48 | $129K | 121K |
| 2025-08-11 | Maryland Patricia Anne | Director | Sell | 0 | $0.00 | $0 | 25K |
| 2025-08-11 | Maryland Patricia Anne | Director | Sell | 20K | $22.74 | $455K | 5K |
| 2025-08-11 | DeLuca Teresa | Director | Sell | 20K | $22.74 | $455K | 45K |
| 2025-08-08 | Doherty David T | Chief Financial Officer | Sell | 47K | $23.39 | $1.1M | 103K |
| 2025-06-10 | TURNER BRENT | Director | Grant | 7K | $23.32 | $160K | 75K |
| 2025-06-10 | Maryland Patricia Anne | Director | Grant | 7K | $23.32 | $160K | 25K |
| 2025-06-10 | HENDRIX BLAIR E | Director, 10% owner | Grant | 7K | $23.32 | $160K | 50.0M |
| 2025-06-10 | Forese Laura L | Director | Grant | 7K | $23.32 | $160K | 7K |
| 2025-06-10 | Deane John A | Director | Grant | 7K | $23.32 | $160K | 34K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON31 Form 144 notices on file for SGRY worth $14.4M at the prices reported; 0 in the last 90 days worth $0. Latest: Jason Eric Evans filed on 2026-03-16 to sell 20,400 shares ($254K) from 2026-03-16.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-03-16 | Jason Eric EvansDirector, Officer | 20K | $254K | 0.016% | 2026-03-16 | UBS Financial Services Inc |
| 2026-03-16 | David DohertyOfficer | 9K | $111K | 0.007% | 2026-03-16 | UBS Financial Services Inc |
| 2026-03-13 | Danielle BurkhalterOfficer | 3K | $45K | 0.003% | 2026-03-13 | UBS Financial Services Inc |
| 2026-03-13 | Marissa BrittenhamOfficer | 4K | $46K | 0.003% | 2026-03-13 | UBS Financial Services Inc |
| 2026-03-12 | William T. WebbOfficer | 2K | $27K | 0.002% | 2026-03-12 | UBS Financial Services Inc |
| 2026-03-12 | Jennifer BaldockOfficer | 6K | $76K | 0.004% | 2026-03-12 | UBS Financial Services Inc |
| 2026-03-06 | William T. WebbOfficer | 272 | $4K | 0.000% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-06 | Jason Eric EvansOfficer, Director | 11K | $158K | 0.009% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-06 | David DohertyOfficer | 15K | $202K | 0.011% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-06 | Danielle BurkhalterOfficer | 8K | $105K | 0.006% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-06 | Marissa BrittenhamOfficer | 9K | $120K | 0.007% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-06 | Jennifer BaldockOfficer | 10K | $138K | 0.008% | 2026-03-06 | UBS Financial Services Inc |
| 2026-03-05 | William T. WebbOfficer | 2K | $25K | 0.001% | 2026-03-05 | UBS Financial Services Inc |
| 2025-10-24 | Wayne DeVeydtformer director | 3K | $65K | 0.002% | 2025-10-24 | UBS Financial Services Inc |
| 2025-10-23 | Wayne DeVeydtformer director | 31K | $666K | 0.024% | 2025-10-23 | UBS Financial Services Inc |
| 2025-10-22 | Wayne DeVeydtformer director | 25K | $533K | 0.020% | 2025-10-22 | UBS Financial Services Inc |
| 2025-10-21 | Wayne DeVeydtformer director | 41K | $858K | 0.032% | 2025-10-21 | UBS Financial Services Inc |
| 2025-10-20 | Wayne DeVeydtformer director | 5K | $109K | 0.004% | 2025-10-20 | UBS Financial Services Inc |
| 2025-10-16 | Wayne DeVeydtformer director | 53K | $1.1M | 0.041% | 2025-10-16 | UBS Financial Services Inc |
| 2025-10-15 | Wayne DeVeydtformer director | 25K | $527K | 0.020% | 2025-10-15 | UBS Financial Services Inc |
| 2025-10-14 | Wayne DeVeydtformer director | 25K | $514K | 0.019% | 2025-10-14 | UBS Financial Services Inc |
| 2025-10-09 | Wayne DeVeydtformer director | 3K | $65K | 0.002% | 2025-10-09 | UBS Financial Services Inc |
| 2025-10-08 | Wayne DeVeydtformer director | 25K | $513K | 0.019% | 2025-10-08 | UBS Financial Services Inc |
| 2025-09-29 | Wayne DeVeydtformer director | 18K | $400K | 0.014% | 2025-09-29 | UBS Financial Services Inc |
| 2025-09-26 | Wayne DeVeydtformer director | 6K | $124K | 0.004% | 2025-09-26 | UBS Financial Services Inc |
| 2025-09-23 | Wayne DeVeydtformer director | 25K | $550K | 0.019% | 2025-09-23 | UBS Financial Services Inc |
| 2025-09-22 | Wayne DeVeydtformer director | 50K | $1.1M | 0.039% | 2025-09-22 | UBS Financial Services Inc |
| 2025-09-19 | Wayne DeVeydtformer director | 11K | $235K | 0.008% | 2025-09-19 | UBS Financial Services Inc |
| 2025-09-18 | Wayne DeVeydtformer director | 150K | $3.3M | 0.117% | 2025-09-18 | UBS Financial Services Inc |
| 2025-09-17 | Wayne DeVeydtformer director | 86K | $1.9M | 0.067% | 2025-09-17 | UBS Financial Services Inc |
| 2025-09-16 | Wayne DeVeydtformer director | 25K | $542K | 0.019% | 2025-09-16 | UBS Financial Services Inc |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of SGRY in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP PLC at 10.2% of the class (13,036,583 shares), filed 2025-11-14 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | King Street Capital Management GP, L.L.C.parent holding company | 6.1M | 4.6% | 2026-06-30 |
| 2026-08-14 | 13G | King Street Capital Management, L.P.investment adviser | 6.1M | 4.6% | 2026-06-30 |
| 2026-08-14 | 13G | Brian J. Higginsparent holding company | 6.1M | 4.6% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 3 | Pentwater Capital Management LPinvestment adviser, partnership | 12.7M | 9.7% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 3 | Matthew Halbowerparent holding company, individual | 12.7M | 9.7% | 2026-03-31 |
| 2026-05-06 | 13G/Ano. 7 | FMR LLCparent holding company | 2.2M | 1.7% | 2026-03-31 |
| 2026-05-06 | 13G/Ano. 7 | Abigail P. Johnsonindividual | 2.2M | 1.7% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 2 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-14 | 13G/Ano. 3 | JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company | 13.0M | 10.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | Janus Henderson Contrarian Fundinvestment company | 12.5M | 9.7% | 2025-09-30 |
13F holders
Tracked managers holding SGRY at their latest 13F. JSON3 of the 30 tracked managers held SGRY at their latest 13F, $7.9M in total at quarter-end prices. Citadel Advisors is the largest at $4.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 291K | $4.9M | 0.00% | -110K |
| Renaissance Technologies | 2026-06-30 | 130K | $2.2M | 0.00% | new |
| AQR Capital Management | 2026-06-30 | 46K | $775K | 0.00% | +34K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Surgery Partners in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Surgery Partners (SGRY), SEC CIK 1638833, listed on Nasdaq, classified by the SEC as services-general medical & surgical hospitals, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-03-16.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-18.JSON and CSV
- Company record
- EDGAR filing index for CIK 1638833Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-general medical & surgical hospitals, nec
Other company pages
- MUMicron Technology
- NVDANVIDIA
- METAMeta Platforms
- SNDKSandisk
- SPCXSpaceX
- TSLATesla
- AAPLApple
- AMDAdvanced Micro Devices
- INTCIntel
- MSFTMicrosoft
- AMZNAmazon.com
- GOOGLAlphabet
- AVGOBroadcom
- GOOGAlphabet
- BEBloom Energy
- ORCLOracle
- DELLDell Technologies
- LITELumentum Holdings
- TSMTaiwan Semiconductor Manufacturing
- MRVLMarvell Technology
Datasets
Frequently Asked Questions
How much of SGRY is sold short?
14,349,417 shares were held short at the 2026-09-30 settlement, 5.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is SGRY's daily short volume?
On 2026-10-09, 158,042 of the 323,370 SGRY shares reported to FINRA were sold short, 48.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does SGRY have fails to deliver?
The SEC's latest file shows 55,678 SGRY shares failed to deliver at settlement 2026-09-11. Fails are reported per settlement date and published twice a month with a lag.
Are SGRY insiders buying or selling?
Insiders at SGRY reported 1 open-market buy worth $144K in the last 90 days and no open-market sells. Latest filing: DeLuca Teresa (Director) on 2026-08-18.
Have SGRY insiders filed to sell?
31 Form 144 notices on file for SGRY worth $14.4M at the prices reported; 0 in the last 90 days worth $0. Latest: Jason Eric Evans filed on 2026-03-16 to sell 20,400 shares ($254K) from 2026-03-16.
Who owns 5% or more of SGRY?
4 holders report 5% or more of SGRY in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP PLC at 10.2% of the class (13,036,583 shares), filed 2025-11-14 for an event on 2025-09-30.
Which tracked 13F managers own SGRY?
3 of the 30 tracked 13F managers held SGRY shares at their latest filing, $7.9M in all. The largest: Ken Griffin's Citadel Advisors (291K shares, $4.9M), Renaissance Technologies (130K shares, $2.2M), Cliff Asness's AQR Capital Management (46K shares, $775K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.